Veritas, AZB act on Swedish firm Recipharm's acquisition of Kemwell businesses

Bar & Bench April 21 2016

Recipharm AB, a Swedish a pharmaceutical contract development and manufacturing organisation (CDMO) is acquiring Kemwell’s CDMO businesses in India, US and Sweden in a strategic deal worth $ 205 million (1360 crore).

Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates, Natasha Sethna and Tejasvi Saxena.

AZB & Partners acted for Kemwell and the team included Partners Srinath Dasari and Nanditha Gopal and Associates Bhuvana Veeraragavan . . .

You need to have an active subscription to view this content.